ATOH1 and hearing loss disorder: Moreover, using transient expression of Atoh1 in already differentiated HCs might prolong their viability (Yang et al., 2012), possibly long enough to sidestep the need for OC regeneration in elderly people suffering from early stages of neurosensory hearing loss.